Research Study

Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients: A Pilot Study
Principal Investigator 
John Gill

Overview

Body Locations and Systems 
Kidney Transplantation
ClinicalTrials.gov# 
NCT02426502
Status 
Recruiting
Study Start/End 
Apr 13, 2015 to May 1, 2021
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Shinhye Kim, Research Coordinator
Phone 
604-682-2344 ext.64706
Purpose of Study 

Patient failure to take medications as prescribed (medication non-adherence) is now identified as an important cause of kidney transplant failure. The availability of new drugs that are taken once daily may improve patient adherence compared to older drugs that had to be taken twice per day. In this study, patients will be converted to a medication schedule where all medications are taken once daily with the goal of improving patient adherence and satisfaction.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.